NL
ARKG icon

NWAM LLC’s ARK Genomic Revolution ETF ARKG Stock Holding History

NWAM LLC’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.33M Buy
31,704
+11,294
+55% +$360K 0.07% 273
2026
Q1 		$539K Buy
20,410
+5,244
+35% +$154K 0.03% 386
2025
Q4 		$439K Buy
+15,166
New +$455K 0.02% 418
2022
Q2 		– Sell
-4,712
Closed -$216K – 514
2022
Q1 		$216K Buy
+4,712
New +$225K 0.02% 497
2021
Q3 		– Sell
-2,906
Closed -$269K – 496
2021
Q2 		$269K Buy
2,906
+421
+17% +$35.8K 0.03% 396
2021
Q1 		$220K Buy
+2,485
New +$246K 0.02% 441

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

NWAM LLC's ARKG Position: Q2 2026 in Review

NWAM LLC increased its ARK Genomic Revolution ETF (ARKG) stake by 55% in Q2 2026, buying an estimated $360K and bringing the position to 31,704 shares worth $1.33M. The position accounts for 0.07% of the portfolio, ranked #273.

NWAM LLC first reported a position in ARKG in Q1 2021 and has held it in 6 quarters since. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • NWAM LLC held 31,704 shares of ARK Genomic Revolution ETF worth $1.33M as of Q2 2026.
  • NWAM LLC bought 11,294 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $360K.
  • ARK Genomic Revolution ETF made up 0.07% of NWAM LLC's portfolio in Q2 2026, its #273 holding.
  • NWAM LLC first reported a position in ARK Genomic Revolution ETF in Q1 2021 and has held it in 6 quarters since.
  • 272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on NWAM LLC's 13F filing for Q2 2026, filed 23 Jul 2026.